Global Rapid Microbiology Testing Market 2023-2027

Description

List of Tables

Technavio has been monitoring the rapid microbiology testing market and it is poised to grow by $2,487.91 mn during 2023-2027, accelerating at a CAGR of 9.31% during the forecast period. Our report on the rapid microbiology testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of infectious disease and cancer, rise in geriatric population, and the high prevalence of food-borne diseases.

Technavio's rapid microbiology testing market is segmented as below:

By End-user

Hospitals and diagnostic laboratories
Pharmaceutical and biotechnology companies
Others

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the rise in food safety concerns as one of the prime reasons driving the rapid microbiology testing market growth during the next few years. Also, advances in technology and the rise in the adoption of microbiology testing for the diagnosis will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the rapid microbiology testing market covers the following areas:

Rapid microbiology testing market sizing
Rapid microbiology testing market forecast
Rapid microbiology testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rapid microbiology testing market vendors that include Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Biosensia Ltd., Bruker Corp., Charles River Laboratories, Colifast AS, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, Gradientech AB, Merck KGaA, Neogen Corp., Quidel Corp., Rapid Micro Biosystems Inc., rqMicro AG, Sartorius AG, Serosep Ltd., Solus Scientific Ltd., and Thermo Fisher Scientific Inc. Also, the rapid microbiology testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74724

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Method
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global rapid microbiology testing market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global rapid microbiology testing market 2017 - 2021 ($ million)
4.2 Method Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Method Segment 2017 - 2021 ($ million)
4.3 End-User Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Method

6.1 Market segments
Exhibit 30: Chart on Method - Market share 2022-2027 (%)
Exhibit 31: Data Table on Method - Market share 2022-2027 (%)
6.2 Comparison by Method
Exhibit 32: Chart on Comparison by Method
Exhibit 33: Data Table on Comparison by Method
6.3 Growth-based - Market size and forecast 2022-2027
Exhibit 34: Chart on Growth-based - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Growth-based - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Growth-based - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Growth-based - Year-over-year growth 2022-2027 (%)
6.4 Nucleic-acid based - Market size and forecast 2022-2027
Exhibit 38: Chart on Nucleic-acid based - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Nucleic-acid based - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Nucleic-acid based - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Nucleic-acid based - Year-over-year growth 2022-2027 (%)
6.5 Viability-based - Market size and forecast 2022-2027
Exhibit 42: Chart on Viability-based - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Viability-based - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Viability-based - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Viability-based - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Method
Exhibit 50: Market opportunity by Method ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 53: Chart on Comparison by End-user
Exhibit 54: Data Table on Comparison by End-user
7.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 55: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
7.4 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
Exhibit 59: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 67: Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Asia - Market size and forecast 2022-2027
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 116: Abbott Laboratories - Overview
Exhibit 117: Abbott Laboratories - Business segments
Exhibit 118: Abbott Laboratories - Key news
Exhibit 119: Abbott Laboratories - Key offerings
Exhibit 120: Abbott Laboratories - Segment focus
12.4 Becton Dickinson and Co.
Exhibit 121: Becton Dickinson and Co. - Overview
Exhibit 122: Becton Dickinson and Co. - Business segments
Exhibit 123: Becton Dickinson and Co. - Key news
Exhibit 124: Becton Dickinson and Co. - Key offerings
Exhibit 125: Becton Dickinson and Co. - Segment focus
12.5 bioMerieux SA
Exhibit 126: bioMerieux SA - Overview
Exhibit 127: bioMerieux SA - Product / Service
Exhibit 128: bioMerieux SA - Key offerings
12.6 Bruker Corp.
Exhibit 129: Bruker Corp. - Overview
Exhibit 130: Bruker Corp. - Business segments
Exhibit 131: Bruker Corp. - Key news
Exhibit 132: Bruker Corp. - Key offerings
Exhibit 133: Bruker Corp. - Segment focus
12.7 Charles River Laboratories
Exhibit 134: Charles River Laboratories - Overview
Exhibit 135: Charles River Laboratories - Business segments
Exhibit 136: Charles River Laboratories - Key news
Exhibit 137: Charles River Laboratories - Key offerings
Exhibit 138: Charles River Laboratories - Segment focus
12.8 Danaher Corp.
Exhibit 139: Danaher Corp. - Overview
Exhibit 140: Danaher Corp. - Business segments
Exhibit 141: Danaher Corp. - Key news
Exhibit 142: Danaher Corp. - Key offerings
Exhibit 143: Danaher Corp. - Segment focus
12.9 Don Whitley Scientific Ltd.
Exhibit 144: Don Whitley Scientific Ltd. - Overview
Exhibit 145: Don Whitley Scientific Ltd. - Product / Service
Exhibit 146: Don Whitley Scientific Ltd. - Key offerings
12.10 Gradientech AB
Exhibit 147: Gradientech AB - Overview
Exhibit 148: Gradientech AB - Product / Service
Exhibit 149: Gradientech AB - Key offerings
12.11 Merck KGaA
Exhibit 150: Merck KGaA - Overview
Exhibit 151: Merck KGaA - Business segments
Exhibit 152: Merck KGaA - Key news
Exhibit 153: Merck KGaA - Key offerings
Exhibit 154: Merck KGaA - Segment focus
12.12 Neogen Corp.
Exhibit 155: Neogen Corp. - Overview
Exhibit 156: Neogen Corp. - Business segments
Exhibit 157: Neogen Corp. - Key news
Exhibit 158: Neogen Corp. - Key offerings
Exhibit 159: Neogen Corp. - Segment focus
12.13 Quidel Corp.
Exhibit 160: Quidel Corp. - Overview
Exhibit 161: Quidel Corp. - Product / Service
Exhibit 162: Quidel Corp. - Key offerings
12.14 Rapid Micro Biosystems Inc.
Exhibit 163: Rapid Micro Biosystems Inc. - Overview
Exhibit 164: Rapid Micro Biosystems Inc. - Product / Service
Exhibit 165: Rapid Micro Biosystems Inc. - Key offerings
12.15 rqMicro AG
Exhibit 166: rqMicro AG - Overview
Exhibit 167: rqMicro AG - Product / Service
Exhibit 168: rqMicro AG - Key offerings
12.16 Sartorius AG
Exhibit 169: Sartorius AG - Overview
Exhibit 170: Sartorius AG - Business segments
Exhibit 171: Sartorius AG - Key news
Exhibit 172: Sartorius AG - Key offerings
Exhibit 173: Sartorius AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 174: Thermo Fisher Scientific Inc. - Overview
Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
Exhibit 176: Thermo Fisher Scientific Inc. - Key news
Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations